IL17A and asthma: In the present study, we evaluated the expression levels of activation‐ and function‐related genes in interleukin (IL)‐5‐ or IL‐17‐activated eosinophils derived from patients receiving Global Initiative for Asthma (GINA) 4 or 5 treatment and those receiving GINA 3 treatment.